Search

BiomX announced on December 8, 2025 that it was discontinuing its Phase 2b trial of BX004 in cystic fibrosis patients with chronic Pseudomonas aeruginosa infections, saying the time and resources needed for the alternative dosing strategy r

Cytophage Announces Closing of Non-Brokered Private Placement and Filing of Q3 Financials. Cytophage News Releases

Cytophage Announces Closing of First Tranche of Non-Brokered Private Placement. Cytophage News Releases

The Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, is hosting the 6th International Conference on Bacteriophage Research and Antimicrobial Resistance (ICBRAR-2025) under the Society for Bacteriophage Re

Cytophage Announces Closing Date of its Non-Brokered Private Placement. Cytophage News Releases

The Centre of Biological Engineering at the University of Minho is leading the establishment of a Laboratory for the Production of Therapeutic Phages to address antibiotic resistance. University of Minho / CEB

The European Medicines Agency's draft guideline on quality aspects of phage therapy medicinal products (EMA/CHMP/BWP/1/2024) clarifies the regulatory expectations for quality documentation of bacteriophage active substances and finished pro

A team of Imperial scientists from Life Sciences and Medicine has received approximately £2.7 million through a Wellcome Trust Discovery Award to study capsid-forming phage-inducible chromosomal islands (cf-PICIs), which release tail-less c

Cytophage Announces Non-Brokered Private Placement. Cytophage News Releases

Australia's Therapeutic Goods Administration consulted on a proposed time-limited GMP exemption for manufacturers of personalised bacteriophage therapy products, which are currently supplied as unapproved goods under the Special Access Sche

Baylor University will partner with academic and industry investigators on MIGHTY, a five-year initiative funded up to $28 million by ARPA-H. The project aims to develop a precision phage platform, starting with oral health. Aaron Wright wi

Cytophage Announces the Commercialization of OvaPhage in Canada Through W.L.T. Distributors Inc. Cytophage News Releases

Project coordinator Esme discussed using phage therapy to treat urinary tract infections with Melissa Kramer of Live UTI Free. The Phage Collection Project

Paris-based Phagos has raised a €25 million Series A co-led by CapAgro, Hoxton Ventures, CapHorn and Demeter. The funds will go to deploying its veterinary phage treatments in the field, developing the next generation of its AI phage-discov

The Phage Collection Project announced that its Phage Therapy VR experience was available to download. The Phage Collection Project

MicrobiotiX, a Korean bacteriophage-therapy company, completed an extended Series B totaling 20 billion KRW (29 billion KRW raised across rounds). It was also selected for the Korean Ministry of Health and Welfare's Infectious Disease Preve

University of Toronto researchers report in Nature that the phage protein Zip reduces the number and length of pili on Pseudomonas aeruginosa and, they hypothesize, prevents self-infection so that viral progeny can reach new hosts, a phenom

Lake Forest College alumna Laurel Robbins (’23), a PhD candidate in biochemistry at the University of Colorado Boulder, received a 2025 National Science Foundation Graduate Research Fellowship, securing funding for tuition, stipend and fees

CARB-X awarded PHIOGEN $1.1 million to evaluate PHI-BI-01, a phage-based candidate designed to treat and prevent ExPEC bloodstream infections. The project aims to pair immediate treatment with longer-term immune protection. CARB-X

Dr Andrew Millard's team at the University of Leicester has analysed dung samples from nearly every animal at Dudley Zoo to build a large phage library for finding phages that best fight different bacterial infections. Droppings contain man